124 related articles for article (PubMed ID: 11967036)
1. AM3 (Inmunoferón) as an adjuvant to hepatitis B vaccination in hemodialysis patients.
Pérez-García R; Pérez-García A; Verbeelen D; Bernstein ED; Villarrubia VG; Alvarez-Mon M
Kidney Int; 2002 May; 61(5):1845-52. PubMed ID: 11967036
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
Alavian SM; Tabatabaei SV
Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
[TBL] [Abstract][Full Text] [Related]
4. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving hemodialysis.
Ahuja TS; Kumar S; Mansoury H; Rodriguez H; Kuo YF
Kidney Int; 2005 Mar; 67(3):1136-41. PubMed ID: 15698455
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease.
Janssen RS; Mangoo-Karim R; Pergola PE; Girndt M; Namini H; Rahman S; Bennett SR; Heyward WL; Martin JT
Vaccine; 2013 Nov; 31(46):5306-13. PubMed ID: 23727422
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
Kapoor D; Aggarwal SR; Singh NP; Thakur V; Sarin SK
J Viral Hepat; 1999 Sep; 6(5):405-9. PubMed ID: 10607257
[TBL] [Abstract][Full Text] [Related]
9. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
Sali S; Alavian SM; Hajarizadeh B
Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
[TBL] [Abstract][Full Text] [Related]
10. Effect of adding levamisole on seroconversion response to hepatitis B virus vaccination in hemodialysis patients: a single-center experience.
Sanadgol H; Khoshnoodi M; Mashhadi MA; Forghani MS
Iran J Kidney Dis; 2011 Sep; 5(5):338-41. PubMed ID: 21876312
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
Singh NP; Mandal SK; Thakur A; Kapoor D; Anuradha S; Prakash A; Kohli R; Agarwal SK
Ren Fail; 2003 Mar; 25(2):255-66. PubMed ID: 12739832
[TBL] [Abstract][Full Text] [Related]
13. [New vaccination protocol against hepatitis B for hemodialysis patients--a single-centre experience].
Resić H; Kukavica N; Masnić F; Prohić N; Sahović V; Ajanović S; Corić A; Avdić E; Helać-Cvijetić D
Acta Med Croatica; 2011 Dec; 65(5):405-14. PubMed ID: 22994011
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
Jha R; Lakhtakia S; Jaleel MA; Narayan G; Hemlatha K
Ren Fail; 2001 Sep; 23(5):629-36. PubMed ID: 11725909
[TBL] [Abstract][Full Text] [Related]
15. [Long-term evaluation of immune response to hepatitis B vaccine in 136 patients undergoing hemodialysis].
Pin M; Compte MT; Angelet P; Gállego C; Gutiérrez C; Martinez Vea A
Nefrologia; 2009; 29(5):415-20. PubMed ID: 19820753
[TBL] [Abstract][Full Text] [Related]
16. Protection against muscle damage in competitive sports players: the effect of the immunomodulator AM3.
Córdova A; Martin JF; Reyes E; Alvarez-Mon M
J Sports Sci; 2004 Sep; 22(9):827-33. PubMed ID: 15513276
[TBL] [Abstract][Full Text] [Related]
17. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
Liu YL; Kao MT; Huang CC
Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
Chow KM; Law MC; Leung CB; Szeto CC; Li PK
Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of chronic hepatitis B by anti HBV vaccine.
Pol S; Couillin I; Michel ML; Driss F; Nalpas B; Carnot F; Berthelot P; Bréchot C
Acta Gastroenterol Belg; 1998; 61(2):228-33. PubMed ID: 9658616
[TBL] [Abstract][Full Text] [Related]
20. Polymethylmethacrylate strengthens antibody response in hemodialysis patients not responding to hepatitis B vaccine: preliminary data.
Duranti E; Duranti D
Minerva Med; 2011 Dec; 102(6):469-74. PubMed ID: 22193378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
